SRX5210678 GSM3543768 SRP176285 SRS4214993 GSM3543768 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543768 GSM3543768 GEO Accession GSM3543768 SRX5210679 GSM3543769 SRP176285 SRS4214995 GSM3543769 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543769 GSM3543769 GEO Accession GSM3543769 SRX5210680 GSM3543770 SRP176285 SRS4214997 GSM3543770 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543770 GSM3543770 GEO Accession GSM3543770 SRX5210681 GSM3543771 SRP176285 SRS4214994 GSM3543771 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543771 GSM3543771 GEO Accession GSM3543771 SRX5210682 GSM3543772 SRP176285 SRS4214996 GSM3543772 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543772 GSM3543772 GEO Accession GSM3543772 SRX5210683 GSM3543773 SRP176285 SRS4214998 GSM3543773 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543773 GSM3543773 GEO Accession GSM3543773 SRX5210684 GSM3543774 SRP176285 SRS4214999 GSM3543774 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543774 GSM3543774 GEO Accession GSM3543774 SRX5210685 GSM3543775 SRP176285 SRS4215000 GSM3543775 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543775 GSM3543775 GEO Accession GSM3543775 SRX5210686 GSM3543776 SRP176285 SRS4215001 GSM3543776 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543776 GSM3543776 GEO Accession GSM3543776 SRX5210687 GSM3543777 SRP176285 SRS4215002 GSM3543777 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543777 GSM3543777 GEO Accession GSM3543777 SRX5210688 GSM3543778 SRP176285 SRS4215003 GSM3543778 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543778 GSM3543778 GEO Accession GSM3543778 SRX5210689 GSM3543779 SRP176285 SRS4215004 GSM3543779 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543779 GSM3543779 GEO Accession GSM3543779 SRX5210690 GSM3543780 SRP176285 SRS4215005 GSM3543780 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543780 GSM3543780 GEO Accession GSM3543780 SRX5210691 GSM3543781 SRP176285 SRS4215007 GSM3543781 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543781 GSM3543781 GEO Accession GSM3543781 SRX5210692 GSM3543782 SRP176285 SRS4215006 GSM3543782 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543782 GSM3543782 GEO Accession GSM3543782 SRX5210693 GSM3543783 SRP176285 SRS4215008 GSM3543783 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543783 GSM3543783 GEO Accession GSM3543783 SRX5210694 GSM3543816 SRP176285 SRS4215009 GSM3543816 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543816 GSM3543816 GEO Accession GSM3543816 SRX5210695 GSM3543817 SRP176285 SRS4215010 GSM3543817 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543817 GSM3543817 GEO Accession GSM3543817 SRX5210696 GSM3543818 SRP176285 SRS4215011 GSM3543818 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543818 GSM3543818 GEO Accession GSM3543818 SRX5210697 GSM3543819 SRP176285 SRS4215013 GSM3543819 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543819 GSM3543819 GEO Accession GSM3543819 SRX5210698 GSM3543820 SRP176285 SRS4215012 GSM3543820 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543820 GSM3543820 GEO Accession GSM3543820 SRX5210699 GSM3543821 SRP176285 SRS4215014 GSM3543821 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543821 GSM3543821 GEO Accession GSM3543821 SRX5210700 GSM3543784 SRP176285 SRS4215015 GSM3543784 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543784 GSM3543784 GEO Accession GSM3543784 SRX5210701 GSM3543785 SRP176285 SRS4215016 GSM3543785 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543785 GSM3543785 GEO Accession GSM3543785 SRX5210702 GSM3543786 SRP176285 SRS4215017 GSM3543786 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543786 GSM3543786 GEO Accession GSM3543786 SRX5210703 GSM3543787 SRP176285 SRS4215018 GSM3543787 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543787 GSM3543787 GEO Accession GSM3543787 SRX5210704 GSM3543788 SRP176285 SRS4215020 GSM3543788 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543788 GSM3543788 GEO Accession GSM3543788 SRX5210705 GSM3543789 SRP176285 SRS4215019 GSM3543789 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543789 GSM3543789 GEO Accession GSM3543789 SRX5210706 GSM3543790 SRP176285 SRS4215021 GSM3543790 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543790 GSM3543790 GEO Accession GSM3543790 SRX5210707 GSM3543791 SRP176285 SRS4215022 GSM3543791 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543791 GSM3543791 GEO Accession GSM3543791 SRX5210708 GSM3543792 SRP176285 SRS4215023 GSM3543792 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543792 GSM3543792 GEO Accession GSM3543792 SRX5210709 GSM3543793 SRP176285 SRS4215024 GSM3543793 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543793 GSM3543793 GEO Accession GSM3543793 SRX5210710 GSM3543794 SRP176285 SRS4215026 GSM3543794 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543794 GSM3543794 GEO Accession GSM3543794 SRX5210711 GSM3543795 SRP176285 SRS4215025 GSM3543795 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543795 GSM3543795 GEO Accession GSM3543795 SRX5210712 GSM3543796 SRP176285 SRS4215028 GSM3543796 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543796 GSM3543796 GEO Accession GSM3543796 SRX5210713 GSM3543797 SRP176285 SRS4215029 GSM3543797 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543797 GSM3543797 GEO Accession GSM3543797 SRX5210714 GSM3543798 SRP176285 SRS4215027 GSM3543798 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543798 GSM3543798 GEO Accession GSM3543798 SRX5210715 GSM3543799 SRP176285 SRS4215030 GSM3543799 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543799 GSM3543799 GEO Accession GSM3543799 SRX5210716 GSM3543800 SRP176285 SRS4215031 GSM3543800 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543800 GSM3543800 GEO Accession GSM3543800 SRX5210717 GSM3543801 SRP176285 SRS4215032 GSM3543801 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543801 GSM3543801 GEO Accession GSM3543801 SRX5210718 GSM3543802 SRP176285 SRS4215034 GSM3543802 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543802 GSM3543802 GEO Accession GSM3543802 SRX5210719 GSM3543803 SRP176285 SRS4215033 GSM3543803 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543803 GSM3543803 GEO Accession GSM3543803 SRX5210720 GSM3543804 SRP176285 SRS4215035 GSM3543804 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543804 GSM3543804 GEO Accession GSM3543804 SRX5210721 GSM3543805 SRP176285 SRS4215036 GSM3543805 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543805 GSM3543805 GEO Accession GSM3543805 SRX5210722 GSM3543806 SRP176285 SRS4215037 GSM3543806 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543806 GSM3543806 GEO Accession GSM3543806 SRX5210723 GSM3543807 SRP176285 SRS4215038 GSM3543807 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543807 GSM3543807 GEO Accession GSM3543807 SRX5210724 GSM3543808 SRP176285 SRS4215039 GSM3543808 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543808 GSM3543808 GEO Accession GSM3543808 SRX5210725 GSM3543809 SRP176285 SRS4215040 GSM3543809 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543809 GSM3543809 GEO Accession GSM3543809 SRX5210726 GSM3543810 SRP176285 SRS4215041 GSM3543810 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543810 GSM3543810 GEO Accession GSM3543810 SRX5210727 GSM3543811 SRP176285 SRS4215043 GSM3543811 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543811 GSM3543811 GEO Accession GSM3543811 SRX5210728 GSM3543812 SRP176285 SRS4215042 GSM3543812 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543812 GSM3543812 GEO Accession GSM3543812 SRX5210729 GSM3543813 SRP176285 SRS4215044 GSM3543813 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543813 GSM3543813 GEO Accession GSM3543813 SRX5210730 GSM3543814 SRP176285 SRS4215045 GSM3543814 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543814 GSM3543814 GEO Accession GSM3543814 SRX5210731 GSM3543815 SRP176285 SRS4215046 GSM3543815 RNA-Seq TRANSCRIPTOMIC cDNA The treated cells were harvested, and the cell pellets were snap frozen with liquid nitrogen and stored at−80°C.Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. After quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo Fisher Scientific), the quality of the total RNA was verified on a Bioanalyzer by Cancer Genome Facility (SA, Australia) ensuring all samples had RINs >7.0. For both cell lines, the sequencing was performed in Ramaciotti Centrefor Genomics (NSW, Australia). The sample preparation for each cell line was TruSeq Stranded mRNA-seq with dual indexed, on the NextSeq500 v2 platform. The parameter was 75bp paired-end High Output. Total RNA was isolated with PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer's protocol (Rev: 21 May 2012).  Sample preparation were employing TruSeq Stranded mRNA Library Prep Kit (Illumina) with 1μg input total RNA. NextSeq 500 gds 303543815 GSM3543815 GEO Accession GSM3543815